Ardent Health Inc. (NYSE: ARDT) Stock Competitors & Peer Comparison
See ARDT's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ARDT and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ARDT | $18.50 | +16.35% | 2.4B | 13.95 | $1.24 | N/A |
| HCA | $505.17 | -0.46% | 103.4B | 17.09 | $28.96 | +0.62% |
| THC | $293.70 | +2.53% | 22.5B | 16.43 | $17.24 | N/A |
| EHC | $139.87 | -0.99% | 13.6B | 23.56 | $5.84 | +0.57% |
| FMS | $22.97 | -2.94% | 12.5B | 8.80 | $2.66 | +3.70% |
| DVA | $187.72 | -3.65% | 12B | 13.56 | $14.11 | N/A |
| ENSG | $182.30 | -0.05% | 10.6B | 26.23 | $6.90 | +0.14% |
| UHS | $198.21 | -0.19% | 10.1B | 8.67 | $22.54 | +0.41% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| PACS | $49.54 | -1.31% | 7.9B | 26.23 | $1.89 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
ARDT vs HCA Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, HCA has a market cap of 103.4B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while HCA trades at $505.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas HCA's P/E ratio is 17.09. In terms of profitability, ARDT's ROE is +0.09%, compared to HCA's ROE of -1.00%. Regarding short-term risk, ARDT is more volatile compared to HCA. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
ARDT vs THC Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, THC has a market cap of 22.5B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while THC trades at $293.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas THC's P/E ratio is 16.43. In terms of profitability, ARDT's ROE is +0.09%, compared to THC's ROE of +0.61%. Regarding short-term risk, ARDT is more volatile compared to THC. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check THC's competition here
Encompass Health Corporation (NYSE: EHC)
ARDT vs EHC Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, EHC has a market cap of 13.6B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while EHC trades at $139.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas EHC's P/E ratio is 23.56. In terms of profitability, ARDT's ROE is +0.09%, compared to EHC's ROE of +0.25%. Regarding short-term risk, ARDT is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check EHC's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
ARDT vs FMS Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, FMS has a market cap of 12.5B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while FMS trades at $22.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas FMS's P/E ratio is 8.80. In terms of profitability, ARDT's ROE is +0.09%, compared to FMS's ROE of +0.06%. Regarding short-term risk, ARDT is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check FMS's competition here
DaVita Inc. (NYSE: DVA)
ARDT vs DVA Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, DVA has a market cap of 12B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while DVA trades at $187.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas DVA's P/E ratio is 13.56. In terms of profitability, ARDT's ROE is +0.09%, compared to DVA's ROE of -1.33%. Regarding short-term risk, ARDT is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check DVA's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
ARDT vs ENSG Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, ENSG has a market cap of 10.6B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while ENSG trades at $182.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas ENSG's P/E ratio is 26.23. In terms of profitability, ARDT's ROE is +0.09%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, ARDT is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check ENSG's competition here
Universal Health Services, Inc. (NYSE: UHS)
ARDT vs UHS Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, UHS has a market cap of 10.1B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while UHS trades at $198.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas UHS's P/E ratio is 8.67. In terms of profitability, ARDT's ROE is +0.09%, compared to UHS's ROE of +0.20%. Regarding short-term risk, ARDT is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check UHS's competition here
Oak Street Health, Inc. (NYSE: OSH)
ARDT vs OSH Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas OSH's P/E ratio is -17.65. In terms of profitability, ARDT's ROE is +0.09%, compared to OSH's ROE of +4.64%. Regarding short-term risk, ARDT is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
ARDT vs PACS Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, PACS has a market cap of 7.9B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while PACS trades at $49.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas PACS's P/E ratio is 26.23. In terms of profitability, ARDT's ROE is +0.09%, compared to PACS's ROE of +0.26%. Regarding short-term risk, ARDT is more volatile compared to PACS. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check PACS's competition here
Chemed Corporation (NYSE: CHE)
ARDT vs CHE Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, CHE has a market cap of 6.9B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while CHE trades at $538.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas CHE's P/E ratio is 24.44. In terms of profitability, ARDT's ROE is +0.09%, compared to CHE's ROE of +0.32%. Regarding short-term risk, ARDT is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check CHE's competition here
Hims & Hers Health, Inc. (NYSE: HIMS)
ARDT vs HIMS Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, HIMS has a market cap of 5.8B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while HIMS trades at $23.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas HIMS's P/E ratio is -40.62. In terms of profitability, ARDT's ROE is +0.09%, compared to HIMS's ROE of -0.30%. Regarding short-term risk, ARDT is less volatile compared to HIMS. This indicates lower risk in terms of short-term price fluctuations for ARDT.Check HIMS's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
ARDT vs CON Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, CON has a market cap of 5.4B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while CON trades at $42.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas CON's P/E ratio is 26.54. In terms of profitability, ARDT's ROE is +0.09%, compared to CON's ROE of +0.48%. Regarding short-term risk, ARDT is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check CON's competition here
LHC Group, Inc. (NASDAQ: LHCG)
ARDT vs LHCG Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas LHCG's P/E ratio is 82.83. In terms of profitability, ARDT's ROE is +0.09%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, ARDT is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
ARDT vs LFST Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, LFST has a market cap of 5.3B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while LFST trades at $14.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas LFST's P/E ratio is 103.71. In terms of profitability, ARDT's ROE is +0.09%, compared to LFST's ROE of +0.05%. Regarding short-term risk, ARDT is less volatile compared to LFST. This indicates lower risk in terms of short-term price fluctuations for ARDT.Check LFST's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
ARDT vs OPCH Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, OPCH has a market cap of 4.7B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while OPCH trades at $31.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas OPCH's P/E ratio is 18.40. In terms of profitability, ARDT's ROE is +0.09%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, ARDT is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check OPCH's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
ARDT vs ACHC Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, ACHC has a market cap of 3.4B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while ACHC trades at $38.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas ACHC's P/E ratio is 18.58. In terms of profitability, ARDT's ROE is +0.09%, compared to ACHC's ROE of -0.57%. Regarding short-term risk, ARDT is more volatile compared to ACHC. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check ACHC's competition here
Amedisys, Inc. (NASDAQ: AMED)
ARDT vs AMED Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas AMED's P/E ratio is 39.30. In terms of profitability, ARDT's ROE is +0.09%, compared to AMED's ROE of +0.04%. Regarding short-term risk, ARDT is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check AMED's competition here
National HealthCare Corporation (AMEX: NHC)
ARDT vs NHC Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, NHC has a market cap of 3.3B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while NHC trades at $212.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas NHC's P/E ratio is 26.46. In terms of profitability, ARDT's ROE is +0.09%, compared to NHC's ROE of +0.10%. Regarding short-term risk, ARDT is more volatile compared to NHC. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check NHC's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
ARDT vs SGRY Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, SGRY has a market cap of 3B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while SGRY trades at $26.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas SGRY's P/E ratio is 59.45. In terms of profitability, ARDT's ROE is +0.09%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, ARDT is more volatile compared to SGRY. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check SGRY's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
ARDT vs AVAH Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, AVAH has a market cap of 2.9B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while AVAH trades at $13.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas AVAH's P/E ratio is 19.47. In terms of profitability, ARDT's ROE is +0.09%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, ARDT is more volatile compared to AVAH. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check AVAH's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
ARDT vs GRDN Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, GRDN has a market cap of 2.7B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while GRDN trades at $45.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas GRDN's P/E ratio is 37.14. In terms of profitability, ARDT's ROE is +0.09%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, ARDT is less volatile compared to GRDN. This indicates lower risk in terms of short-term price fluctuations for ARDT.Check GRDN's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
ARDT vs MD Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, MD has a market cap of 2.4B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while MD trades at $31.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas MD's P/E ratio is 13.96. In terms of profitability, ARDT's ROE is +0.09%, compared to MD's ROE of +0.17%. Regarding short-term risk, ARDT is more volatile compared to MD. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check MD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
ARDT vs ADUS Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, ADUS has a market cap of 2.3B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while ADUS trades at $124.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas ADUS's P/E ratio is 18.61. In terms of profitability, ARDT's ROE is +0.09%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, ARDT is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check ADUS's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
ARDT vs BKD Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, BKD has a market cap of 2.2B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while BKD trades at $9.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas BKD's P/E ratio is -15.64. In terms of profitability, ARDT's ROE is +0.09%, compared to BKD's ROE of +0.89%. Regarding short-term risk, ARDT is more volatile compared to BKD. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check BKD's competition here
Select Medical Holdings Corporation (NYSE: SEM)
ARDT vs SEM Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, SEM has a market cap of 2B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas SEM's P/E ratio is 15.43. In terms of profitability, ARDT's ROE is +0.09%, compared to SEM's ROE of +0.08%. Regarding short-term risk, ARDT is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check SEM's competition here
Agilon Health, Inc. (NYSE: AGL)
ARDT vs AGL Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, AGL has a market cap of 1.9B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while AGL trades at $113.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas AGL's P/E ratio is -7.33. In terms of profitability, ARDT's ROE is +0.09%, compared to AGL's ROE of -0.52%. Regarding short-term risk, ARDT is more volatile compared to AGL. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check AGL's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
ARDT vs AMEH Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas AMEH's P/E ratio is 39.25. In terms of profitability, ARDT's ROE is +0.09%, compared to AMEH's ROE of +0.06%. Regarding short-term risk, ARDT is more volatile compared to AMEH. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check AMEH's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
ARDT vs ASTH Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, ASTH has a market cap of 1.7B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while ASTH trades at $33.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas ASTH's P/E ratio is 41.61. In terms of profitability, ARDT's ROE is +0.09%, compared to ASTH's ROE of +0.07%. Regarding short-term risk, ARDT is more volatile compared to ASTH. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check ASTH's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
ARDT vs HCSG Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, HCSG has a market cap of 1.6B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while HCSG trades at $25.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas HCSG's P/E ratio is 16.30. In terms of profitability, ARDT's ROE is +0.09%, compared to HCSG's ROE of +0.20%. Regarding short-term risk, ARDT is more volatile compared to HCSG. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check HCSG's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
ARDT vs SNDA Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, SNDA has a market cap of 1.6B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while SNDA trades at $33.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas SNDA's P/E ratio is -5.29. In terms of profitability, ARDT's ROE is +0.09%, compared to SNDA's ROE of -0.19%. Regarding short-term risk, ARDT is more volatile compared to SNDA. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check SNDA's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
ARDT vs USPH Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, USPH has a market cap of 1.5B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while USPH trades at $98.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas USPH's P/E ratio is 39.17. In terms of profitability, ARDT's ROE is +0.09%, compared to USPH's ROE of -0.00%. Regarding short-term risk, ARDT is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check USPH's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
ARDT vs AMN Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, AMN has a market cap of 1.4B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while AMN trades at $37.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas AMN's P/E ratio is 11.98. In terms of profitability, ARDT's ROE is +0.09%, compared to AMN's ROE of +0.15%. Regarding short-term risk, ARDT is more volatile compared to AMN. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check AMN's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
ARDT vs PNTG Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, PNTG has a market cap of 1.3B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while PNTG trades at $37.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas PNTG's P/E ratio is 27.55. In terms of profitability, ARDT's ROE is +0.09%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, ARDT is more volatile compared to PNTG. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check PNTG's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
ARDT vs NUTX Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, NUTX has a market cap of 1.2B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while NUTX trades at $193.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas NUTX's P/E ratio is 7.15. In terms of profitability, ARDT's ROE is +0.09%, compared to NUTX's ROE of +0.44%. Regarding short-term risk, ARDT is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for ARDT.Check NUTX's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
ARDT vs BKDT Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas BKDT's P/E ratio is N/A. In terms of profitability, ARDT's ROE is +0.09%, compared to BKDT's ROE of +0.89%. Regarding short-term risk, ARDT is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check BKDT's competition here
Innovage Holding Corp. (NASDAQ: INNV)
ARDT vs INNV Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, INNV has a market cap of 1.2B. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while INNV trades at $9.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas INNV's P/E ratio is -448.00. In terms of profitability, ARDT's ROE is +0.09%, compared to INNV's ROE of +0.04%. Regarding short-term risk, ARDT is more volatile compared to INNV. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check INNV's competition here
Talkspace, Inc. (NASDAQ: TALK)
ARDT vs TALK Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, TALK has a market cap of 870.6M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas TALK's P/E ratio is 774.34. In terms of profitability, ARDT's ROE is +0.09%, compared to TALK's ROE of +0.00%. Regarding short-term risk, ARDT is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check TALK's competition here
Enhabit, Inc. (NYSE: EHAB)
ARDT vs EHAB Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas EHAB's P/E ratio is -197.14. In terms of profitability, ARDT's ROE is +0.09%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, ARDT is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check EHAB's competition here
GMR Solutions Inc. (NYSE: GMRS)
ARDT vs GMRS Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, GMRS has a market cap of 672.6M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while GMRS trades at $11.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas GMRS's P/E ratio is -6.13. In terms of profitability, ARDT's ROE is +0.09%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, ARDT is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for ARDT.Check GMRS's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
ARDT vs TOI Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas TOI's P/E ratio is -14.25. In terms of profitability, ARDT's ROE is +0.09%, compared to TOI's ROE of +1.51%. Regarding short-term risk, ARDT is more volatile compared to TOI. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check TOI's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
ARDT vs SRTA Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, SRTA has a market cap of 491M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while SRTA trades at $5.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas SRTA's P/E ratio is -26.16. In terms of profitability, ARDT's ROE is +0.09%, compared to SRTA's ROE of -0.09%. Regarding short-term risk, ARDT is more volatile compared to SRTA. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check SRTA's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
ARDT vs MCTA Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas MCTA's P/E ratio is 419.36. In terms of profitability, ARDT's ROE is +0.09%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, ARDT is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check MCTA's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
ARDT vs STLN Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, STLN has a market cap of 360.9M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while STLN trades at $4.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas STLN's P/E ratio is -11.83. In terms of profitability, ARDT's ROE is +0.09%, compared to STLN's ROE of +1.51%. Regarding short-term risk, ARDT is less volatile compared to STLN. This indicates lower risk in terms of short-term price fluctuations for ARDT.Check STLN's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
ARDT vs VMD Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, VMD has a market cap of 347.6M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while VMD trades at $8.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas VMD's P/E ratio is 25.35. In terms of profitability, ARDT's ROE is +0.09%, compared to VMD's ROE of +0.11%. Regarding short-term risk, ARDT is more volatile compared to VMD. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check VMD's competition here
Auna S.A. (NYSE: AUNA)
ARDT vs AUNA Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, AUNA has a market cap of 346M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while AUNA trades at $4.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas AUNA's P/E ratio is 4.21. In terms of profitability, ARDT's ROE is +0.09%, compared to AUNA's ROE of +0.01%. Regarding short-term risk, ARDT is more volatile compared to AUNA. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check AUNA's competition here
Community Health Systems, Inc. (NYSE: CYH)
ARDT vs CYH Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, CYH has a market cap of 311.7M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while CYH trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas CYH's P/E ratio is 3.03. In terms of profitability, ARDT's ROE is +0.09%, compared to CYH's ROE of +0.36%. Regarding short-term risk, ARDT is more volatile compared to CYH. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check CYH's competition here
Capital Senior Living Corporation (NYSE: CSU)
ARDT vs CSU Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas CSU's P/E ratio is 0.67. In terms of profitability, ARDT's ROE is +0.09%, compared to CSU's ROE of -0.23%. Regarding short-term risk, ARDT is more volatile compared to CSU. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check CSU's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
ARDT vs FVE Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas FVE's P/E ratio is -5.64. In terms of profitability, ARDT's ROE is +0.09%, compared to FVE's ROE of -0.15%. Regarding short-term risk, ARDT is more volatile compared to FVE. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check FVE's competition here
The Joint Corp. (NASDAQ: JYNT)
ARDT vs JYNT Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, JYNT has a market cap of 96.7M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while JYNT trades at $6.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas JYNT's P/E ratio is 45.60. In terms of profitability, ARDT's ROE is +0.09%, compared to JYNT's ROE of +0.30%. Regarding short-term risk, ARDT is more volatile compared to JYNT. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check JYNT's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
ARDT vs KDLYW Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas KDLYW's P/E ratio is N/A. In terms of profitability, ARDT's ROE is +0.09%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, ARDT is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for ARDT.Check KDLYW's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
ARDT vs PARK Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, PARK has a market cap of 94.5M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while PARK trades at $21.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas PARK's P/E ratio is 26.86. In terms of profitability, ARDT's ROE is +0.09%, compared to PARK's ROE of -0.18%. Regarding short-term risk, ARDT is less volatile compared to PARK. This indicates lower risk in terms of short-term price fluctuations for ARDT.Check PARK's competition here
biote Corp. (NASDAQ: BTMD)
ARDT vs BTMD Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, BTMD has a market cap of 46.8M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while BTMD trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas BTMD's P/E ratio is 9.64. In terms of profitability, ARDT's ROE is +0.09%, compared to BTMD's ROE of +0.03%. Regarding short-term risk, ARDT is more volatile compared to BTMD. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check BTMD's competition here
AlerisLife Inc. (NASDAQ: ALR)
ARDT vs ALR Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas ALR's P/E ratio is -1.11. In terms of profitability, ARDT's ROE is +0.09%, compared to ALR's ROE of -0.15%. Regarding short-term risk, ARDT is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check ALR's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
ARDT vs EUDA Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, EUDA has a market cap of 40.8M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while EUDA trades at $14.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas EUDA's P/E ratio is -11.69. In terms of profitability, ARDT's ROE is +0.09%, compared to EUDA's ROE of -5.06%. Regarding short-term risk, ARDT is more volatile compared to EUDA. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check EUDA's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
ARDT vs CCEL Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, CCEL has a market cap of 39.9M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while CCEL trades at $5.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas CCEL's P/E ratio is -21.50. In terms of profitability, ARDT's ROE is +0.09%, compared to CCEL's ROE of +0.16%. Regarding short-term risk, ARDT is more volatile compared to CCEL. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check CCEL's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
ARDT vs AIRS Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, AIRS has a market cap of 38.7M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while AIRS trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas AIRS's P/E ratio is -17.91. In terms of profitability, ARDT's ROE is +0.09%, compared to AIRS's ROE of -0.09%. Regarding short-term risk, ARDT is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for ARDT.Check AIRS's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
ARDT vs IMAC Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas IMAC's P/E ratio is -2.27. In terms of profitability, ARDT's ROE is +0.09%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, ARDT is more volatile compared to IMAC. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check IMAC's competition here
DocGo Inc. (NASDAQ: DCGO)
ARDT vs DCGO Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, DCGO has a market cap of 24.7M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while DCGO trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas DCGO's P/E ratio is -0.13. In terms of profitability, ARDT's ROE is +0.09%, compared to DCGO's ROE of -1.16%. Regarding short-term risk, ARDT is more volatile compared to DCGO. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check DCGO's competition here
Cano Health, Inc. (NYSE: CANO-WT)
ARDT vs CANO-WT Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, ARDT's ROE is +0.09%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, ARDT is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for ARDT.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
ARDT vs AIH Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas AIH's P/E ratio is -2.78. In terms of profitability, ARDT's ROE is +0.09%, compared to AIH's ROE of +1.16%. Regarding short-term risk, ARDT is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for ARDT.Check AIH's competition here
P3 Health Partners Inc. (NASDAQ: PIIIW)
ARDT vs PIIIW Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, PIIIW has a market cap of 13.9M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas PIIIW's P/E ratio is N/A. In terms of profitability, ARDT's ROE is +0.09%, compared to PIIIW's ROE of +1.61%. Regarding short-term risk, ARDT is more volatile compared to PIIIW. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check PIIIW's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
ARDT vs PIII Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, PIII has a market cap of 13.1M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while PIII trades at $4.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas PIII's P/E ratio is -0.12. In terms of profitability, ARDT's ROE is +0.09%, compared to PIII's ROE of +1.61%. Regarding short-term risk, ARDT is more volatile compared to PIII. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check PIII's competition here
Cano Health, Inc. (NYSE: CANO)
ARDT vs CANO Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas CANO's P/E ratio is -0.01. In terms of profitability, ARDT's ROE is +0.09%, compared to CANO's ROE of -1.49%. Regarding short-term risk, ARDT is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for ARDT.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
ARDT vs FPCG Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas FPCG's P/E ratio is 0.09. In terms of profitability, ARDT's ROE is +0.09%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, ARDT is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check FPCG's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
ARDT vs FTRP Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas FTRP's P/E ratio is -1.22. In terms of profitability, ARDT's ROE is +0.09%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, ARDT is more volatile compared to FTRP. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check FTRP's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
ARDT vs BMGL Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, BMGL has a market cap of 8.4M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while BMGL trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas BMGL's P/E ratio is -1.06. In terms of profitability, ARDT's ROE is +0.09%, compared to BMGL's ROE of -0.11%. Regarding short-term risk, ARDT is more volatile compared to BMGL. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check BMGL's competition here
American Shared Hospital Services (AMEX: AMS)
ARDT vs AMS Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, AMS has a market cap of 7.8M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while AMS trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas AMS's P/E ratio is -4.63. In terms of profitability, ARDT's ROE is +0.09%, compared to AMS's ROE of -0.07%. Regarding short-term risk, ARDT is more volatile compared to AMS. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check AMS's competition here
ModivCare Inc. (NASDAQ: MODV)
ARDT vs MODV Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas MODV's P/E ratio is -0.06. In terms of profitability, ARDT's ROE is +0.09%, compared to MODV's ROE of +0.88%. Regarding short-term risk, ARDT is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
ARDT vs GBNH Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas GBNH's P/E ratio is -0.06. In terms of profitability, ARDT's ROE is +0.09%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, ARDT is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for ARDT.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE)
ARDT vs RHE Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas RHE's P/E ratio is -1.79. In terms of profitability, ARDT's ROE is +0.09%, compared to RHE's ROE of +1.09%. Regarding short-term risk, ARDT is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for ARDT.Check RHE's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
ARDT vs RHE-PA Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, ARDT's ROE is +0.09%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, ARDT is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for ARDT.Check RHE-PA's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
ARDT vs TOIIW Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, ARDT's ROE is +0.09%, compared to TOIIW's ROE of +1.51%. Regarding short-term risk, ARDT is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check TOIIW's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
ARDT vs AIDX Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, AIDX has a market cap of 2.5M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while AIDX trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas AIDX's P/E ratio is -0.27. In terms of profitability, ARDT's ROE is +0.09%, compared to AIDX's ROE of -3.87%. Regarding short-term risk, ARDT is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for ARDT.Check AIDX's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
ARDT vs IMACW Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas IMACW's P/E ratio is N/A. In terms of profitability, ARDT's ROE is +0.09%, compared to IMACW's ROE of +0.46%. Regarding short-term risk, ARDT is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for ARDT.Check IMACW's competition here
Starling Oncology Inc. Wt (NASDAQ: STLNW)
ARDT vs STLNW Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, STLNW has a market cap of 1.2M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while STLNW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas STLNW's P/E ratio is -0.04. In terms of profitability, ARDT's ROE is +0.09%, compared to STLNW's ROE of +1.51%. Regarding short-term risk, ARDT is less volatile compared to STLNW. This indicates lower risk in terms of short-term price fluctuations for ARDT.Check STLNW's competition here
Endovia Health Sciences, Inc. (AMEX: EDVA)
ARDT vs EDVA Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, EDVA has a market cap of 1.2M. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while EDVA trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas EDVA's P/E ratio is -0.01. In terms of profitability, ARDT's ROE is +0.09%, compared to EDVA's ROE of N/A. Regarding short-term risk, ARDT is more volatile compared to EDVA. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check EDVA's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
ARDT vs EUDAW Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, EUDAW has a market cap of 616.3K. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas EUDAW's P/E ratio is -0.01. In terms of profitability, ARDT's ROE is +0.09%, compared to EUDAW's ROE of -5.06%. Regarding short-term risk, ARDT is more volatile compared to EUDAW. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check EUDAW's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
ARDT vs NIVF Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, NIVF has a market cap of 552.8K. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while NIVF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas NIVF's P/E ratio is 0.22. In terms of profitability, ARDT's ROE is +0.09%, compared to NIVF's ROE of -292.08%. Regarding short-term risk, ARDT is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for ARDT.Check NIVF's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
ARDT vs CCM Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, CCM has a market cap of 536.9K. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while CCM trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas CCM's P/E ratio is -1.25. In terms of profitability, ARDT's ROE is +0.09%, compared to CCM's ROE of +0.05%. Regarding short-term risk, ARDT is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for ARDT.Check CCM's competition here
Talkspace, Inc. (NASDAQ: TALKW)
ARDT vs TALKW Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas TALKW's P/E ratio is 0.00. In terms of profitability, ARDT's ROE is +0.09%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, ARDT is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for ARDT.Check TALKW's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
ARDT vs MNDR Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, MNDR has a market cap of 23.3K. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while MNDR trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas MNDR's P/E ratio is -0.06. In terms of profitability, ARDT's ROE is +0.09%, compared to MNDR's ROE of -0.31%. Regarding short-term risk, ARDT is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for ARDT.Check MNDR's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
ARDT vs NIVFW Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, NIVFW has a market cap of 20.5K. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while NIVFW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas NIVFW's P/E ratio is N/A. In terms of profitability, ARDT's ROE is +0.09%, compared to NIVFW's ROE of -292.08%. Regarding short-term risk, ARDT is less volatile compared to NIVFW. This indicates lower risk in terms of short-term price fluctuations for ARDT.Check NIVFW's competition here
Tenon Medical, Inc. (NASDAQ: TNONW)
ARDT vs TNONW Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, TNONW has a market cap of 5.6K. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while TNONW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas TNONW's P/E ratio is N/A. In terms of profitability, ARDT's ROE is +0.09%, compared to TNONW's ROE of N/A. Regarding short-term risk, ARDT is less volatile compared to TNONW. This indicates lower risk in terms of short-term price fluctuations for ARDT.Check TNONW's competition here
Hanger, Inc. (NYSE: HNGR)
ARDT vs HNGR Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, HNGR has a market cap of 0. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas HNGR's P/E ratio is 19.71. In terms of profitability, ARDT's ROE is +0.09%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, ARDT is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check HNGR's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
ARDT vs SLHGP Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, ARDT's ROE is +0.09%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, ARDT is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check SLHGP's competition here
New Frontier Health Corporation (NYSE: NFH)
ARDT vs NFH Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, NFH has a market cap of 0. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas NFH's P/E ratio is -19.75. In terms of profitability, ARDT's ROE is +0.09%, compared to NFH's ROE of -0.06%. Regarding short-term risk, ARDT is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check NFH's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
ARDT vs SLHG Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, SLHG has a market cap of 0. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas SLHG's P/E ratio is -1.48. In terms of profitability, ARDT's ROE is +0.09%, compared to SLHG's ROE of N/A. Regarding short-term risk, ARDT is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for ARDT.Check SLHG's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
ARDT vs ATIP-WT Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, ARDT's ROE is +0.09%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, ARDT is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for ARDT.Check ATIP-WT's competition here
Almost Family Inc. (NASDAQ: AFAM)
ARDT vs AFAM Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, AFAM has a market cap of 0. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas AFAM's P/E ratio is N/A. In terms of profitability, ARDT's ROE is +0.09%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, ARDT is more volatile compared to AFAM. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
ARDT vs TLMD Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, TLMD has a market cap of 0. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas TLMD's P/E ratio is -1.60. In terms of profitability, ARDT's ROE is +0.09%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, ARDT is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check TLMD's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
ARDT vs DVCR Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, DVCR has a market cap of 0. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas DVCR's P/E ratio is 28.34. In terms of profitability, ARDT's ROE is +0.09%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, ARDT is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check DVCR's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
ARDT vs TLMDW Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas TLMDW's P/E ratio is N/A. In terms of profitability, ARDT's ROE is +0.09%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, ARDT is more volatile compared to TLMDW. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check TLMDW's competition here
Kindred Healthcare, Inc. (NYSE: KND)
ARDT vs KND Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, KND has a market cap of 0. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas KND's P/E ratio is -1.14. In terms of profitability, ARDT's ROE is +0.09%, compared to KND's ROE of -0.53%. Regarding short-term risk, ARDT is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check KND's competition here
DocGo Inc. (NASDAQ: DCGOW)
ARDT vs DCGOW Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas DCGOW's P/E ratio is N/A. In terms of profitability, ARDT's ROE is +0.09%, compared to DCGOW's ROE of -1.16%. Regarding short-term risk, ARDT is more volatile compared to DCGOW. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check DCGOW's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
ARDT vs TVTY Comparison November 2026
Ardent Health Inc. (NYSE: ARDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARDT stands at 2.4B. In comparison, TVTY has a market cap of 0. Regarding current trading prices, ARDT is priced at $18.50 on the NYSE, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARDT currently has a P/E ratio of 13.95, whereas TVTY's P/E ratio is 19.06. In terms of profitability, ARDT's ROE is +0.09%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, ARDT is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for ARDT.Check TVTY's competition here